Agilon Health, Inc. (NYSE:AGL) Receives Consensus Rating of “Hold” from Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have received an average recommendation of “Hold” from the seventeen research firms that are presently covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $2.7083.

A number of research firms have commented on AGL. Royal Bank Of Canada raised shares of Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a research report on Wednesday, January 21st. Barclays decreased their price target on shares of Agilon Health from $1.50 to $1.00 and set an “underweight” rating for the company in a report on Thursday, November 6th. Zacks Research raised shares of Agilon Health from a “strong sell” rating to a “hold” rating in a research report on Tuesday, October 21st. Finally, Wells Fargo & Company cut their target price on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating on the stock in a report on Wednesday, November 5th.

Agilon Health Stock Performance

Shares of Agilon Health stock opened at $0.82 on Thursday. Agilon Health has a 1 year low of $0.51 and a 1 year high of $6.08. The firm’s 50-day simple moving average is $0.77 and its 200-day simple moving average is $1.04. The firm has a market cap of $340.37 million, a PE ratio of -1.09 and a beta of 0.05.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.09). Agilon Health had a negative net margin of 5.24% and a negative return on equity of 75.92%. The firm had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. On average, equities analysts predict that Agilon Health will post -0.59 earnings per share for the current year.

Institutional Trading of Agilon Health

Hedge funds have recently made changes to their positions in the stock. Wealth Enhancement Advisory Services LLC grew its position in Agilon Health by 5.6% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 105,324 shares of the company’s stock valued at $256,000 after purchasing an additional 5,627 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in Agilon Health by 3.5% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after buying an additional 7,209 shares in the last quarter. Dynamic Technology Lab Private Ltd boosted its stake in shares of Agilon Health by 28.4% during the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after buying an additional 10,424 shares during the period. Signaturefd LLC grew its holdings in shares of Agilon Health by 65.1% during the 2nd quarter. Signaturefd LLC now owns 30,479 shares of the company’s stock valued at $70,000 after acquiring an additional 12,018 shares in the last quarter. Finally, Apollon Wealth Management LLC grew its holdings in shares of Agilon Health by 17.4% during the 4th quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after acquiring an additional 12,193 shares in the last quarter.

Key Agilon Health News

Here are the key news stories impacting Agilon Health this week:

• Neutral Sentiment: Market commentary notes AGL is trading down and asks whether it is “Time to Sell?” — short market/analysis piece. AGL Trading Down 4% – Time to Sell?
• Negative Sentiment: The Gross Law Firm notifies Agilon shareholders to contact the firm before March 2, 2026 to discuss participation in the pending action. Gross Law Firm Notice
• Negative Sentiment: Faruqi & Faruqi LLP announces an investigation and urges affected investors to contact the firm (reminder of March 2 lead‑plaintiff deadline). Faruqi & Faruqi Alert
• Negative Sentiment: Rosen Law Firm reminds purchasers in the Feb. 26–Aug. 4, 2025 class period of the March 2 deadline in the securities class action it filed. Rosen Law Firm Reminder
• Negative Sentiment: Glancy Prongay & Murray LLP says investors who lost money can seek to lead the securities‑fraud class action against Agilon. Glancy Prongay & Murray Notice
• Negative Sentiment: Levi & Korsinsky notifies Agilon investors to contact the firm before March 2 to discuss their rights in the pending litigation. Levi & Korsinsky Notice
• Negative Sentiment: Kirby McInerney LLP reminds investors of the March 2 lead‑plaintiff deadline and the implications of not filing on time. Kirby McInerney Reminder
• Negative Sentiment: Bragar Eagel & Squire, Robbins LLP, Pomerantz, Bernstein Liebhard and other firms have issued alerts urging affected shareholders to contact them about the class action or lead‑plaintiff role. Bragar Eagel & Squire Alert
• Negative Sentiment: Robbins LLP and Pomerantz LLP similarly urge investors with losses to contact them about leading the suit; each filing increases outreach and potential class‑size. Robbins LLP Notice
• Negative Sentiment: Schall Law Firm and other firms remind investors of the pending securities complaint covering Feb. 26–Aug. 4, 2025 (opportunities to serve as lead plaintiff). Schall Law Firm Notice
• Negative Sentiment: Kaskela Law announces a stockholder investigation and references an earlier securities complaint covering purchases from 2021–2024 — signals potential broader governance/fiduciary concerns. Kaskela Investigation
• Negative Sentiment: Bronstein, Gewirtz & Grossman publicizes that a class action was filed alleging investor harm and invites affected shareholders to act. Bronstein Class Action Alert

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.